CIAM
LGND icon

Caitong International Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Caitong International Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$114 – 2260
2025
Q2 		$114 Sell
1
-2
-67% -$214 ﹤0.01% 1831
2025
Q1 		$315 Sell
3
-87
-97% -$9.84K ﹤0.01% 1864
2024
Q4 		$9.64K Buy
+90
New +$10.2K 0.01% 960

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caitong International Asset Management's LGND Position: Q3 2025 in Review

Caitong International Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2025, closing a stake of 1 share — an estimated $114 sold.

Caitong International Asset Management first reported a position in LGND in Q4 2024 and held it in 3 quarters. The position peaked at $9.64K in Q4 2024. 314 funds tracked by Wall St. Rank hold LGND as of Q3 2025.

  • Caitong International Asset Management reported no remaining Ligand Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 1 Ligand Pharmaceuticals share in Q3 2025, an estimated $114.
  • Caitong International Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Caitong International Asset Management's Ligand Pharmaceuticals position peaked at $9.64K in Q4 2024.
  • 314 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.